Men often work hard to get a BPH treatment insurance at the age of 65 and over but such insurance does not guarantee the chosen treatment option will be helpful and neither that it's safe, whereas new effective Dr. Allen’s device for prostate care cannot harm and is affordably priced at $130, highlights Fine Treatment.
London, UK (PRWEB) August 05, 2012
Fine Treatment recommends a new natural prostate care device for the treatment of benign prostatic hyperplasia (BPH) at home without adverse side effects and affordably priced at $130, while insurance can provide the cover for different costly treatment options, such as long-term courses of medications and surgeries, which have doubtful efficacy but require a high premium to be paid over years. New Thermobalancing Therapy enabled by Dr Allen's device helps to improve the condition of the prostate. Please watch a short video: http://www.youtube.com/watch?v=V5xidswhxJM.
Medicare, a federal health insurance program for people age 65 and older can help to plan the best way to use health coverage a person already has. However, it does not help with chronic health problems and cannot insure a person from complications that typically follow conventional treatments. Each new health problem requires extra-spending, adding pressure on men's finances, and even more so if he is alone. An article titled ‘The high cost of growing old alone’ in The Fiscal-Times, April 2012, states: “Single seniors who also face escalating health care costs are five times more likely to live in poverty as their married peers.”
A free public service from Johns Hopkins Medicine states: Explore all your options for benign prostatic hyperplasia (BPH) treatment. TURP is the gold standard for now, but for many men, PVP is an appropriate and attractive alternative. This is especially true if you can’t stop taking anticoagulants before the procedure or your age or other health conditions make it too risky to undergo the rigors of surgery.
The price of “gold” TURP in the USA, as calculated by D. Bradford in EconPaper in 2002, was the following: “The predicted unconditional cost of TURP ranged from US$8908 to US$3832 (by state); the predicted conditional cost of TURP ranged from US$1163 to US$750. The results suggest that the cost associated with providing a TURP for the average man with BPH would be US$492 to US$1163, depending on the state of residence.” And these prices are going up each year.
“Insurance requires men to be paying a premium over their lifetime but it cannot protect them from the troubling side effects of common treatments,” says Dr. Allen. “Dr. Allen’s therapeutic device helps to improve the condition of the enlarged prostate gland naturally and at a widely affordable price.”
Read more at http://www.finetreatment.co.uk/prostatetreatmentbph/prostatitistreatment.html.
About Dr. Simon Allen and Fine Treatment:
Dr. Simon Allen is a highly experienced medical professional. His specialty is in the internal medicine and cardio-vascular field, and he has treated patients after a heart attack, with kidneys problems, including kidney stones disease, prostate and spine conditions. Fine Treatment exclusively offers Dr Allen’s devices for chronic prostatitis and BPH, coronary heart disease, dissolving kidney stones, as well as back pain treatment and sciatica relief.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebenlargedprostatetreatment/bphtreatment_prostate/prweb9770623.htm
This article (Prostate Surgery and Medications Insurance Does Not Guarantee Their Efficacy and Safety While New Cost-Effective Thermobalancing Therapy Does, States Fine Treatment) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.